Related Experiment Video
Updated: Jun 8, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Drug transport by breast cancer resistance protein
Maren Poguntke1, Eszter Hazai, Martin F Fromm
1University of Erlangen-Nuremberg, Institute of Experimental and Clinical Pharmacology and Toxicology, Fahrstr. 17, 91054 Erlangen, Germany.
Importance Of The Field:
The ATP-binding cassette transporter ABCG2 is a well-known major mediator of multi-drug resistance in cancers. Beyond multi-drug resistance, experimental and recent clinical studies demonstrate a role for ABCG2 as a determinant of drug pharmacokinetic, safety and efficacy profiles.
Areas Covered In This Review:
The clinical evidence of the role of ABCG2 in pharmacokinetics and pharmacodynamics is reviewed. Key questions that arise from the perspective of preclinical drug evaluation are addressed, including the structure of ABCG2 and mechanisms of drug-transporter interactions, mechanisms responsible for the polyspecificity of ABCG2, methods suitable for studying drug-ABCG2 interactions in vitro and in silico prediction of ABCG2 substrates and inhibitors.
What The Reader Will Gain:
An update on current knowledge of the importance of ABCG2 in drug disposition with special emphasis on drug development.
Take Home Message:
The field of drug-ABCG2 interaction is rapidly advancing and beginning to expand into clinical practice. However, the structural understanding of drug binding and transport by ABCG2 is still incomplete. Incorporation of novel concepts of drug-transporter interactions such as electrostatic funneling might help explain the multispecificity of ABCG2 and enable in silico predictions.
Insights
The ATP-binding cassette transporter ABCG2 impacts drug pharmacokinetics, safety, and efficacy. Understanding ABCG2 drug interactions is crucial for effective cancer drug development and personalized medicine.
Area of Science:
- Pharmacology
- Molecular Biology
- Drug Development
Background:
- The ATP-binding cassette transporter ABCG2 is a key factor in cancer multi-drug resistance.
- ABCG2 significantly influences drug pharmacokinetics, safety, and efficacy.
- Recent studies highlight ABCG2's role beyond resistance, impacting drug profiles.
Purpose of the Study:
- To review clinical evidence on ABCG2's role in pharmacokinetics and pharmacodynamics.
- To address preclinical drug evaluation questions regarding ABCG2.
- To provide an update on ABCG2's importance in drug disposition and development.
Main Methods:
- Review of clinical evidence on ABCG2's role.
- Discussion of ABCG2 structure and drug-transporter interactions.
- Exploration of ABCG2 polyspecificity mechanisms.
- Evaluation of in vitro and in silico methods for studying ABCG2 interactions.
Main Results:
- ABCG2 is critical in drug disposition, particularly in drug development.
- Current knowledge emphasizes ABCG2's influence on drug safety and efficacy.
- The review provides an update on ABCG2's role in drug development.
Conclusions:
- Drug-ABCG2 interactions are advancing into clinical practice.
- Structural understanding of ABCG2 binding and transport remains incomplete.
- Novel concepts like electrostatic funneling may explain ABCG2 multispecificity and aid in silico predictions.
More Related Videos
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Treatment Resistant Cancers
ABC Transporters: Exporter

